ライフサイエンスコーパス: elevated intraocular pressure

1 a agonists that are used in the treatment of elevated intraocular pressure.

2 e optic nerve and is usually associated with elevated intraocular pressure.

3 eld defects that is often associated with an elevated intraocular pressure.

4 LK), duration of steroid administration, and elevated intraocular pressure.

5 iridocorneal angle exhibited a significantly elevated intraocular pressure.

6 in vivo following experimental induction of elevated intraocular pressure.

7 be used to treat suspicion of even slightly elevated intraocular pressure.

8 nlarged eye phenotype, presumably because of elevated intraocular pressure.

9 mice form a severely hypomorphic canal with elevated intraocular pressure.

10 p explain the loss of RGCs in the absence of elevated intraocular pressure.

11 ying racial differences in susceptibility to elevated intraocular pressure.

12 ly impede aqueous humor outflow resulting in elevated intraocular pressure.

13 shown to be upregulated in TM in response to elevated intraocular pressure.

14 sues under circumstances of physiological or elevated intraocular pressure.

15 ptic nerve, which is usually associated with elevated intraocular pressure.

16 optic nerve head, frequently associated with elevated intraocular pressure.

17 001), and carboxyfluorescein (P = 0.0064) at elevated intraocular pressures.

18 Elevated intraocular pressure and glaucoma are the most

19 terior segment of the eye frequently develop elevated intraocular pressure and glaucoma.

20 Because elevated intraocular pressure and ischemia are two promi

21 head is specific to tissue remodeling due to elevated intraocular pressure and not secondary to loss

22 iris pigment release and often progresses to elevated intraocular pressure and pigmentary glaucoma (P

23 hat calpain is activated under conditions of elevated intraocular pressure and provide further detail

24 re in mice; TRPV4 knockout animals exhibited elevated intraocular pressure and shortened cilia.

25 e myocilin (MYOC, GLC1A) are associated with elevated intraocular pressure and the development of aut

26 vide insight into a potential contributor to elevated intraocular pressure and thus to probability of

27 After crush injury to the optic nerve, elevated intraocular pressure, and glutamate toxicity, t

28 lular ATP levels in the retina increase with elevated intraocular pressure, and stimulation of P2X(7)

29 Elevated intraocular pressure as the result of abnormal

30 mor from the eye, and the tissue involved in elevated intraocular pressure associated with glaucoma.

31 eterioration related to antiepileptic drugs, elevated intraocular pressure associated with inhaled co

32 s had a suspect optic disc appearance and/or elevated intraocular pressure, but normal visual fields.

33 Glaucoma traditionally is associated with elevated intraocular pressure, but often occurs or may p

34 creased potential ocular side effects (e.g., elevated intraocular pressure, cataracts).

35 If pores are physiological structures, the elevated intraocular pressure characteristic of glaucoma

36 eased flow resistance is responsible for the elevated intraocular pressure characteristic of glaucoma

37 lity, processes that could contribute to the elevated intraocular pressure characteristic of PCG.

38 c/Tigr mRNA in the retina after induction of elevated intraocular pressure compared with that in the

39 This sustained elevated intraocular pressure could lead to higher rates

40 same as those seen in single oil tamponade (elevated intraocular pressure, cystoid macular oedema (C

41 ch decrease the common causal risk factor of elevated intraocular pressure, delay, but cannot prevent

42 on-cultured human eyes, in which DEX-induced elevated intraocular pressure developed.

43 Elevated intraocular pressure due to a reduction in norm

44 A major risk factor for glaucoma is elevated intraocular pressure due to increased resistanc

45 leral permeability was similarly affected by elevated intraocular pressure for water (P = 0.0039), de

46 6%, scleral necrosis in 3%, cataract in 53%, elevated intraocular pressure (from tumor or radiotherap

47 ased incidence of central vein occlusion and elevated intraocular pressure going along with chamber a

48 ve damage, associated visual field loss, and elevated intraocular pressure (>22 mm Hg in both eyes).

49 d to enucleation due to phthisis bulbi), and elevated intraocular pressure in 3 patients (2 eyes in t

50 the TM is thought to be the primary cause of elevated intraocular pressure in primary open-angle glau

51 anism by which laser trabeculoplasty reduces elevated intraocular pressure in primary open-angle glau

52 Elevated intraocular pressure in the RhoAV14-expressing

53 Causes of elevated intraocular pressure included angle infiltratio

54 In DBA/2 retina, elevated intraocular pressure increased microglial IL-6

55 P<0.01), proptosis (64.3% vs 21.2%, P<0.01), elevated intraocular pressure (IOP) (35.7% vs 12.5%, P<0

56 of irreversible vision loss worldwide, with elevated intraocular pressure (IOP) a major risk factor.

57 tomy with mitomycin C (MMC) for uncontrolled elevated intraocular pressure (IOP) after corneal graft

58 Elevated intraocular pressure (IOP) and decreased ocular

59 Elevated intraocular pressure (IOP) and glaucoma are som

60 To determine the incidence of elevated intraocular pressure (IOP) and secondary glauco

61 use of visual impairment and blindness, with elevated intraocular pressure (IOP) as a major causative

62 n optic neuropathy, commonly associated with elevated intraocular pressure (IOP) characterized by opt

63 blindness, remains poorly defined, although elevated intraocular pressure (IOP) contributes to the d

64 tor of primary open-angle glaucoma (POAG) is elevated intraocular pressure (IOP) due to increased aqu

65 Elevated intraocular pressure (IOP) is a major risk fact

66 Because elevated intraocular pressure (IOP) is a major risk fact

67 Elevated intraocular pressure (IOP) is a major risk fact

68 Elevated intraocular pressure (IOP) is a major risk fact

69 Elevated intraocular pressure (IOP) is a risk factor for

70 Elevated intraocular pressure (IOP) is a well-known adve

71 Elevated intraocular pressure (IOP) is an important risk

72 Elevated intraocular pressure (IOP) is an important risk

73 NH) is the likely site of initial injury and elevated intraocular pressure (IOP) is the best-known ri

74 principal site of initial axonal injury, and elevated intraocular pressure (IOP) is the predominant r

75 Elevated intraocular pressure (IOP) is the principal ris

76 coma is a neurodegenerative disease in which elevated intraocular pressure (IOP) leads to progressive

77 To evaluate the effect of acutely elevated intraocular pressure (IOP) on retinal thickness

78 ayer (RNFL) thickness change associated with elevated intraocular pressure (IOP) over a period of tim

79 Optic nerve crush, excitotoxicity, and elevated intraocular pressure (IOP) rat models were used

80 Improving adherence to manage elevated intraocular pressure (IOP) remains an unmet nee

81 nited States and is commonly associated with elevated intraocular pressure (IOP) resulting from dimin

82 Transgenic Col1a1(r/r) mice develop elevated intraocular pressure (IOP) with an open angle a

83 nsgenic (Col1a1(r/r)) mice gradually develop elevated intraocular pressure (IOP) with open angles.

84 Five patients (28%) had elevated intraocular pressure (IOP) within 1 day of trea

85 nerative disease, whose risk factors include elevated intraocular pressure (IOP), age, and genetics,

86 Elevated intraocular pressure (IOP), sensed as mechanica

87 Elevated intraocular pressure (IOP), the major causal ri

88 aly (ARA), variably associate with harmfully elevated intraocular pressure (IOP), which causes glauco

89 Elevated intraocular pressure (IOP), which causes optic

90 is disease are a positive family history and elevated intraocular pressure (IOP), which is also highl

91 nal ischemia-reperfusion injury by transient elevated intraocular pressure (IOP).

92 e transfer tool for the control of nocturnal elevated intraocular pressure (IOP).

93 ments as early as 7 d following induction of elevated intraocular pressure (IOP).

94 alphaGCs) in dark-adapted mouse retinas with elevated intraocular pressure (IOP).

95 rdation, birefringence, and reflectance with elevated intraocular pressure (IOP).

96 s examined after retinal ischemia induced by elevated intraocular pressure (IOP).

97 J mouse model of glaucoma with spontaneously elevated intraocular pressure (IOP).

98 die by apoptosis, generally attributed to an elevated intraocular pressure (IOP).

99 he best-known risk factor for glaucoma is an elevated intraocular pressure (IOP); however, factors le

100 umor outflow structures of the eye result in elevated intraocular pressure (IOP); however, the genes

101 analyzed in GA-immunized versus nonimmunized elevated-intraocular pressure (IOP) rat models of glauco

102 that they display glaucoma phenotypes (i.e., elevated intraocular pressure [IOP], retinal ganglion ce

103 Elevated intraocular pressure is a highly heritable risk

104 Elevated intraocular pressure is a major risk factor for

105 Since elevated intraocular pressure is a significant risk fact

106 Elevated intraocular pressure is associated with glaucom

107 The mechanism of elevated intraocular pressure is increased aqueous outfl

108 Complications included elevated intraocular pressure leading to glaucoma; catar

109 Taken together, elevated intraocular pressure mediated increase in ET(B)

110 mply that treatment of risk factors, such as elevated intraocular pressure, must not be continuously

111 We hypothesize that elevated intraocular pressure occurring during proptosis

112 e clinically observed by examination such as elevated intraocular pressure, optic nerve head appearan

113 te the unfolded protein response and lead to elevated intraocular pressure or glaucoma in aged mice o

114 lowering medications in eyes with persistent elevated intraocular pressure or glaucoma.

115 Multiple entities not associated with elevated intraocular pressure or glaucomatous optic-nerv

116 inflammation (OR 1.73, P < .0001), prolonged elevated intraocular pressure (OR 2.96, P = .0003), and

117 ma (P = .96), retinal detachment (P = .096), elevated intraocular pressure (P = .88), or suprachoroid

118 Elevated intraocular pressure (P<0.001) was associated s

119 - standard deviation [SD], 30.0+/-19.0%) and elevated intraocular pressure (range, 2.4%-64.0%; mean +

120 t common form of glaucoma-include older age, elevated intraocular pressure, sub-Saharan African ethni

121 implantation include hypotony, postoperative elevated intraocular pressure, tube erosion, diplopia, m

122 Elevated intraocular pressure was induced unilaterally b

123 Exposure to elevated intraocular pressure was similar in all groups.

124 ad occurs in response to loss of axons or to elevated intraocular pressure we compared the patterns o

125 glaucomatous mutations in mouse eyes causes elevated intraocular pressure, which is a major phenotyp